Clinical trial
Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With…
NCT00061919 · University College, London, Other · Completed
Key facts
| NCT number | NCT00061919 |
|---|---|
| Title | Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer |
| Official title | A Phase III Randomized, Double Blind, Placebo Controlled Trial Of Carboplatin/Etoposide With Or Without Thalidomide In Small Cell Lung Cancer (Study 12) |
| Lead sponsor | University College, London, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Carboplatin, etoposide & thalidomide, etoposide & placebo |
| Enrollment | 724 |
| Start date | Apr 1, 2003 |
| Primary completion | Feb 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jun 6, 2003 |
| Last update posted | Mar 16, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: